Browsing by Yonsei Author : Lee, Jung-Yun

eperson profile image
Name:
Lee, Jung-Yun [이정윤]
orcid http://orcid.org/0000-0001-7948-1350
Department :
College of Medicine (의과대학) - Dept. of Obstetrics and Gynecology (산부인과학교실)
Scopus ID :
Scopus (56191369600)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 126

This table browses all dspace content
Issue DateTitleJournal Title
2022Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?GYNECOLOGIC ONCOLOGY
2022Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer FRONTIERS IN ONCOLOGY
2022Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test CANCERS
2022Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study FRONTIERS IN ONCOLOGY
2022Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial JOURNAL OF GYNECOLOGIC ONCOLOGY
2022A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN) IN VIVO
2022PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies JOURNAL OF GYNECOLOGIC ONCOLOGY
2022Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer JOURNAL OF GYNECOLOGIC ONCOLOGY
2022Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in KoreaGYNECOLOGIC ONCOLOGY
2022Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer CANCERS
2022Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective studyGYNECOLOGIC ONCOLOGY
2022Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort studyGYNECOLOGIC ONCOLOGY
2022Major clinical research advances in gynecologic cancer in 2021 JOURNAL OF GYNECOLOGIC ONCOLOGY
2022A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial JOURNAL OF GYNECOLOGIC ONCOLOGY
2022Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer Obstetrics & Gynecology Science
2022ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma CELL DEATH & DISEASE
2022Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic ResponseCLINICAL CANCER RESEARCH
2021Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations Journal of Menopausal Medicine
2021Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor ADVANCED SCIENCE
2021CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer KOREAN JOURNAL OF RADIOLOGY
2021Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2021Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeGYNECOLOGIC ONCOLOGY
2021Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448GYNECOLOGIC ONCOLOGY
2021Association between PD-L1 expression and 18 F-FDG uptake in ovarian cancerANNALS OF NUCLEAR MEDICINE
2021Mismatch repair status influences response to fertility-sparing treatment of endometrial cancerAMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
2021A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) JOURNAL OF GYNECOLOGIC ONCOLOGY
2021Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervixMODERN PATHOLOGY
2021Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging Obstetrics & Gynecology Science
2021Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer CANCER RESEARCH AND TREATMENT
2021Effects of Korean Red Ginseng ( Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled TrialJOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
2021Time for enhancing government-led primary prevention of cervical cancerJOURNAL OF GYNECOLOGIC ONCOLOGY
20204-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39 + CD8 T cells from primary and metastatic sites of epithelial ovarian cancers JOURNAL FOR IMMUNOTHERAPY OF CANCER
2020Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041) CANCERS
2020Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapyEUROPEAN JOURNAL OF CANCER
2020Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer CANCER RESEARCH AND TREATMENT
2020Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancerSURGICAL ONCOLOGY-OXFORD
2020Recommendations for gynecologic cancer care during the COVID-19 pandemic JOURNAL OF GYNECOLOGIC ONCOLOGY
2020Pelvic malakoplakia presenting as endometrial cancer: a case report Obstetrics & Gynecology Science
2020Major clinical research advances in gynecologic cancer in 2019 JOURNAL OF GYNECOLOGIC ONCOLOGY
2020Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching Obstetrics & Gynecology Science
2020Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant ChemotherapyJOURNAL OF CLINICAL MEDICINE
2020A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer YONSEI MEDICAL JOURNAL
2020Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancerJOURNAL OF GYNECOLOGIC ONCOLOGY
2020Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer BMC CANCER
2020Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2020Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter studyJOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
2020The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study BMC CANCER
2020Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer BMC CANCER
20204-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular CarcinomaHEPATOLOGY
2020Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapyINTERNATIONAL JOURNAL OF CANCER

Browse

Links